Brokers' take

Tianjin Zhongxin Pharmaceutical Group Corp | Buy (maintained) April 1 close: US$0.945 Target price: US$1.70 UOB Kay Hian, April 1

Tianjin Zhongxin Pharmaceutical Group's reported Q4 and full-year 2018 net profits came in at 158.7 million yuan (S$32.1 million), a 34.3 per cent increase year-on-year, and 561.7 million yuan (+18.0 per cent yoy) respectively. Full-year performance represented 96.4 per cent of our estimate.

Tianjin Zhongxin proposed a final dividend of 2.2 yuan for every 10 shares (+10.0 per cent yoy), bringing…